Leading Players Operating in the Global Active Wound Care Market are MiMedex, Organogenesis, Inc., Osiris Therapeutics, Incorporated, MTF Biologics, Acell Inc., Tissue Regenix, Solsys Medical, and Smith & Nephew

PUNE, India, May 15, 2019 /PRNewswire/ -- Fortune Business Insights published a report, titled "Active Wound Care Market Size, Share and Global Trend by Product Type (Biological Skin Equivalents, Growth Factors, Biological Dressings), Indication (Pressure Ulcers, Diabetic Foot Sores/Ulcers, Lower Limb Ulcers), End User (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025". As per the report, the global active wound care market was worth US$ 1361.7 Mn in the year 2017, and is estimated to reach US$ 2039.9 Mn by the end of 2025. The rising prevalence of chronic diseases is likely to help the global active wound care market exhibit a healthy CAGR of 5.3% between 2017 and 2025.

Sample Pages: https://www.fortunebusinessinsights.com/enquiry/sample/active-wound-care-market-100172

Demand Witnessed in Ulcer Segment Poised to Surge in Response to Rising Prevalence of Diabetes

The global active wound care market is expected to witness significant growth owing to the rising prevalence of ulcers. Moreover, the report predicts that ulcers may account for a significant share in terms of revenue in the global active wound care market. In the ulcer segment, diabetic foot ulcer is anticipated to gain traction as a considerable number of people contract the disease owing to the increasing prevalence of diabetes. In developing countries, foot ulcer is the one of the most common and feared complications associated with diabetes. This was found in a study published by the National Institute of Health (NIH). Also the study has revealed that around 15% of diabetic people in developing countries is likely to get diabetic foot sores or ulcers at some stage of their life. Ulcer healing is more complicated as it is vulnerable to infection and this is the reason the ulcer segment is expected to register a healthy growth rate by 2025.

From a geographical standpoint, North America is projected to offer impressive growth opportunities throughout the forecast period. This is mainly ascribable to the rising prevalence of wounds and diabetic population in North America. In addition to this, presence of sophisticated healthcare infrastructure leading to the rising demand for active wound care products and treatment, drives the active wound care market in this region. However, in the coming years the active wound care market in Asia Pacific is anticipated to show higher rate of growth on account of the high prevalence of unmet medical requirements in the region.

Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/active-wound-care-market-100172

Rapid Lifestyle Changes and Rising Technological Advancements to Drive the Market.

"Aged people are more prone to contract diseases such as venous leg ulcers which takes long healing time. Therefore, the adoption of active wound care treatment is expected to increase in response to the rising geriatric population in the forthcoming years," said a lead analyst at Fortune Business Insights. Increasing government support in terms of funding for research initiatives is another factor aiding the expansion of the active wound management. Also, several technological developments in active wound healing is likely to drive the active wound care market in the forecast years. For instance, MTF Biologics, with the help of technology, introduced a product called Amino Viable Band Membrane in 2018. The main objective of this product was to heal acute and active wounds. Enabled by this factor, other companies are also planning to expand their product portfolio, giving rise to active wound care technologies.

Disparaging Reimbursement Policies and High Cost May Restrict the Growth

On the downside there are certain factors that may limit the global active wound care market to an extent. Unfavorable reimbursement policies on healthcare is one of the main factors impeding the growth of the active wound care market. Also, high cost associated with active wound care products and treatment is another factor that may hamper the growth of the active wound care market.

Request for Customization: https://www.fortunebusinessinsights.com/enquiry/customization/active-wound-care-market-100172

Key Companies Covered in the Report

• MiMedx
• Tissue Regenix
• Smith & Nephew
• Organogenesis Inc.
• Acell Inc.
• Integra Life Sciences
• Solsys Medical
• Osiris Therapeutics, Inc.
• Other Prominent Players

Major Table of Content:

• Market Dynamics
• Key Insights
• Global Active Wound Care Market Analysis, Insights and Forecast – By Product Type
• Biological Skin Equivalents
• Allografts
• Xenografts
• Cell-based Therapies
• Growth Factors
• Epidermal Growth Factors
• Platelet-derived Growth Factors
• Others
• Biological Dressings
• Collagen Dressings
• Active Dressings (Honey Impregnated Dressings, etc.)
• Others
• Global Active Wound Care Market Analysis, Insights and Forecast – By Indication
• Diabetic Foot Ulcers
• Pressure Ulcers
• Lower Limb Ulcers
• Others
• Global Active Wound Care Market Analysis, Insights and Forecast – By End User
• Hospitals
• Clinics
• Home Care Settings
• Others
• Global Active Wound Care Market Analysis, Insights and Forecast – By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Browse Complete Report Details Enabled with Complete Tables and Figures is Available:

https://www.fortunebusinessinsights.com/industry-reports/active-wound-care-market-100172

Browse Related Reports:

1. Global Advanced Wound Care Market Was Valued at US$ 9,273.3 Mn in 2017 and is Projected to be Valued at US$ 13,450.0 Mn by 2025, Exhibiting a CAGR of 4.8%

Increased focus of market players on R&D, combined with increasing per capita healthcare spending in emerging countries, and implementation of reimbursement policies for advanced wound care products are factors driving the growth of the global advanced wound dressings market.

2. Global Hemostatic Agents Market was valued at US$ 3,339.4 Mn in 2017 and is expected to reach US$ 5,441.5 Mn by the end of 2025, exhibiting a CAGR of 6.4%.

The Hemostatic Agents Market in Asia Pacific is expected to grow at a relatively higher CAGR. Baxter (the leading organization in global market), plans to expand its operation in emerging nations such as India and China to enhance its accessibility.

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact us:
Fortune Business Insights Pvt. Ltd. 
308, Supreme Headquarters
Survey No. 36, Baner
Pune-Bangalore Highway
Pune - 411045, Maharashtra, India
US :+1-424-253-0390
UK :+44-2071-939123
APAC :+91-744-740-1245
Email: sales@fortunebusinessinsights.com
Website: https://www.fortunebusinessinsights.com

Logo: https://mma.prnewswire.com/media/881202/Fortune_Business_Insights_Logo.jpg 
Photo: https://mma.prnewswire.com/media/885776/Active_Wound_Care_Market_Infographic.jpg
 

SOURCE Fortune Business Insights